Royalty Pharma plc
RPRX
$32.76
-$0.59-1.77%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 26.13% | 99.31% | 6.03% | -17.22% | -55.92% |
Total Receivables | 8.44% | 6.56% | 1.36% | 1.12% | 5.28% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -38.54% | -76.79% | -26.75% | -77.58% | 9.63% |
Total Current Assets | 18.18% | 41.43% | 3.79% | -12.68% | -40.72% |
|
|||||
Total Current Assets | 18.18% | 41.43% | 3.79% | -12.68% | -40.72% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | 199.38% | -67.41% | -67.90% | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 11.83% | 7.54% | 13.38% | 4.76% | -1.50% |
Total Assets | 9.16% | 11.24% | 13.79% | 3.13% | -5.52% |
|
|||||
Total Accounts Payable | 225.77% | -11.84% | 61.85% | 303.10% | 73.52% |
Total Accrued Expenses | 52.61% | 89.74% | 204.98% | 3.86% | -4.58% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 26.85% | 52.77% | 8.49% | 73.66% | 1.87% |
Total Other Current Liabilities | 26.85% | 52.77% | 8.49% | 73.66% | 1.87% |
Total Current Liabilities | 849.52% | 676.82% | 812.79% | -76.48% | -88.85% |
|
|||||
Total Current Liabilities | 849.52% | 676.82% | 812.79% | -76.48% | -88.85% |
Long-Term Debt | 7.81% | 7.81% | 7.82% | 24.07% | 0.27% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 455.90% | 1,242.22% | -50.62% | 218.13% | -73.82% |
Total Liabilities | 24.77% | 25.13% | 24.13% | 8.17% | -13.58% |
|
|||||
Common Stock & APIC | 3.33% | 2.29% | 2.52% | 1.72% | 8.96% |
Retained Earnings | 2.19% | 13.03% | 29.51% | 5.56% | 9.50% |
Treasury Stock & Other | 0.00% | -1.26% | -1.26% | -1.22% | 6.15% |
Total Common Equity | 2.91% | 6.44% | 11.91% | 3.10% | 9.17% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 2.91% | 6.44% | 11.91% | 3.10% | 9.17% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -7.85% | -4.55% | -1.67% | -7.26% | -13.04% |
Total Equity | -0.76% | 2.56% | 7.03% | -0.63% | 0.42% |
|